ARTICLE | Company News
Opko, Teva deal
October 6, 2008 7:00 AM UTC
Opko acquired exclusive, worldwide rights from Teva to develop and commercialize budesonide for ophthalmic indications including inflammation and allergic ocular conditions. Terms were not disclosed. ...